Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection.
FASEB J
; 35(5): e21577, 2021 05.
Article
in English
| MEDLINE | ID: covidwho-1172658
ABSTRACT
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is an emerging respiratory pathogen that has rapidly spread in human populations. Severe forms of infection associate cytokine release syndrome and acute lung injury due to hyperinflammatory responses even though virus clearance is achieved. Key components of inflammation include immune cell recruitment in infected tissues, a step which is under the control of endothelial cells. Here, we review endothelial cell responses in inflammation and infection due to SARS-CoV-2 together with phenotypic and functional alterations of monocytes, T and B lymphocytes with which they interact. We surmise that endothelial cells function as an integrative and active platform for the various cells recruited, where fine tuning of immune responses takes place and which provides opportunities for therapeutic intervention.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Myeloid Cells
/
Endothelial Cells
/
Adaptive Immunity
/
COVID-19
Limits:
Animals
/
Humans
Language:
English
Journal:
FASEB J
Journal subject:
Biology
/
Physiology
Year:
2021
Document Type:
Article
Affiliation country:
Fj.202100024R
Similar
MEDLINE
...
LILACS
LIS